Results 121 to 130 of about 48,562 (198)

Treatment of Livedoid Vasculopathy with the Janus Kinase Inhibitors: A Case Series. [PDF]

Case Rep Dermatol
Zhao G, Liu Y, Ni J, Song Z.
europepmc   +1 more source

Research progress in electrochemical determination of Janus kinase inhibitors and proposals for amplifying clinical applicability. [PDF]

Mikrochim Acta
Mikus P, Hanko M, Zelinkova Z, Labuda J.
europepmc   +1 more source

Management of Pregnancy in Women with Inflammatory Bowel Disease: Positioning Janus Kinase Inhibitors Within Current Evidence. [PDF]

Curr Issues Mol Biol
Colacurci D, Pellegrino R, Lamart A, Staiano D, De Costanzo I, Izzo M, Imperio G, Landa F, Scamardella G, Di Lella E, Federico A, Sarno L, Gravina AG.   +12 more
europepmc   +1 more source

Safety of biologics and Janus kinase inhibitors in inflammatory bowel disease patients with low cardiovascular risk. [PDF]

Crohns Colitis 360
Patel P, Iqbal O, Mohananey D, Bajwa S, Khani M, Luo J, Stein DJ, Kochhar GS, Hashash JG, Mansoor E, Cross RK, Sinh P.   +11 more
europepmc   +1 more source

Efficacy of Janus kinase inhibitors in the treatment of acute exacerbations of rheumatoid arthritis-associated interstitial lung disease: a retrospective observational case series. [PDF]

Front Immunol
Okamoto M, Fujikawa K, Mihara T, Doi S, Tomari S, Koga T, Kido T, Sakamoto N, Mizokami A, Mukae H, Kawakami A.   +10 more
europepmc   +1 more source

Insurance-driven switching and real-world treatment outcomes of Janus kinase inhibitors in alopecia areata: A retrospective cohort study. [PDF]

J Am Acad Dermatol
Engelking YT, Jabbari A.
europepmc   +1 more source

Janus kinase inhibitors: another potential for uveitis treatment? [PDF]

Ann Eye Sci
Emami S, Kaisari E, Janetos TM.
europepmc   +1 more source

Association of Venous Thromboembolism Risk with Atopic Dermatitis and Janus Kinase Inhibitors Treatment: A Mendelian Randomization Study. [PDF]

Clin Appl Thromb Hemost
Chen Z, Wang S, Wang Y.
europepmc   +1 more source

Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis. [PDF]

Arthritis Res Ther
Nozaki Y, Kishimoto K, Itami T, Tomita D, Wada Y, Kotani T, Takeuchi T, Hidaka T, Hino S, Miyamoto T, Miyake H, Hatta K, Mamoto K, Yamada Y, Okano T, Okano T, Saegusa J, Horita M, Nishida K, Kinoshita K, Rai S.   +20 more
europepmc   +1 more source

Janus Kinase Inhibitors for Treatment of Palmoplantar Pustulosis, Generalized Pustular Psoriasis, and Palmoplantar Pustular Psoriasis: A Systematic Review of the Literature. [PDF]

Health Sci Rep
Ansari MS, Heidari S, Pourgholi E, Bahramian S, Tootoonchi N, Vahabi SM.   +5 more
europepmc   +1 more source